Natus Medical: Here’s What Investors Need to Know Before Earnings

Natus Medical (NASDAQ:BABY) will report earnings before markets open on Wednesday, May 29th. Natus Medical Incorporated is a medical device company that develops, manufactures, and markets screening products. The Company’s products identify and monitor common medical disorders that may occur between conception to a baby’s first birthday. Natus is selling its ALGO products for newborn hearing screening, as well as its CO-Stat products for the evaluation of jaundice.

Here is your Cheat Sheet to Natus Medical Earnings:

Earnings Expectations: Analysts expect earnings of $0.11 per share on revenues of $84.47 million. Currently, the company’s P/E ratio stands at 108.08.

Analyst Trends:

Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.18 to a profit $0.19. For the current year, the average estimate is a profit of $0.84, which is better than the estimate ninety days ago.

Earnings Trends:

Here’s how Natus Medical has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 162 167 219 233 292
Diluted EPS ($) 0.66 0.39 0.41 -0.41 0.12

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 59.51 61.01 80.72 90.45
Diluted EPS ($) 0.01 0.01 -0.07 0.16

Past Performance:
Natus Medical has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)

More Articles About:   , ,  

More from The Cheat Sheet